In the BioHarmony Drug Report Database

"Preview" Icon

Etonogestrel

Implanon, Nexplanon (etonogestrel) is a small molecule pharmaceutical. Etonogestrel was first approved as Implanon on 2006-07-17. Nuvaring’s patents are valid until 2030-07-28 (FDA).

 

Trade Name

 

Implanon, Nexplanon
 

Common Name

 

etonogestrel
 

ChEMBL ID

 

CHEMBL1531
 

Indication

 

 

Drug Class

 

Estrogens; progestins

Image (chem structure or protein)

Etonogestrel structure rendering